Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0008540 | proteasome regulatory particle, base subcomplex | 2 | 11 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0005634 | nucleus | 5 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H561
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 11 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009056 | catabolic process | 2 | 11 |
GO:0009057 | macromolecule catabolic process | 4 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044248 | cellular catabolic process | 3 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 11 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:1901575 | organic substance catabolic process | 3 | 11 |
GO:0010498 | proteasomal protein catabolic process | 5 | 1 |
GO:0030163 | protein catabolic process | 4 | 1 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 4 | 1 |
GO:0140030 | modification-dependent protein binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.519 |
CLV_C14_Caspase3-7 | 326 | 330 | PF00656 | 0.387 |
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.336 |
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.257 |
CLV_NRD_NRD_1 | 284 | 286 | PF00675 | 0.315 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 284 | 286 | PF00082 | 0.315 |
CLV_PCSK_PC1ET2_1 | 108 | 110 | PF00082 | 0.425 |
CLV_Separin_Metazoa | 281 | 285 | PF03568 | 0.370 |
DEG_APCC_KENBOX_2 | 162 | 166 | PF00400 | 0.497 |
DEG_SPOP_SBC_1 | 306 | 310 | PF00917 | 0.630 |
DOC_CYCLIN_yClb1_LxF_4 | 45 | 51 | PF00134 | 0.297 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 174 | 181 | PF00134 | 0.493 |
DOC_MAPK_gen_1 | 105 | 113 | PF00069 | 0.202 |
DOC_MAPK_gen_1 | 130 | 141 | PF00069 | 0.315 |
DOC_MAPK_gen_1 | 284 | 291 | PF00069 | 0.315 |
DOC_MAPK_MEF2A_6 | 133 | 141 | PF00069 | 0.308 |
DOC_MAPK_MEF2A_6 | 284 | 291 | PF00069 | 0.315 |
DOC_MAPK_NFAT4_5 | 284 | 292 | PF00069 | 0.315 |
DOC_PP1_RVXF_1 | 107 | 114 | PF00149 | 0.202 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.596 |
DOC_USP7_MATH_1 | 236 | 240 | PF00917 | 0.494 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.560 |
DOC_USP7_MATH_1 | 307 | 311 | PF00917 | 0.680 |
DOC_USP7_UBL2_3 | 130 | 134 | PF12436 | 0.370 |
DOC_USP7_UBL2_3 | 159 | 163 | PF12436 | 0.475 |
DOC_WW_Pin1_4 | 113 | 118 | PF00397 | 0.252 |
DOC_WW_Pin1_4 | 300 | 305 | PF00397 | 0.723 |
LIG_14-3-3_CanoR_1 | 221 | 225 | PF00244 | 0.277 |
LIG_BRCT_BRCA1_1 | 83 | 87 | PF00533 | 0.147 |
LIG_CaM_IQ_9 | 150 | 165 | PF13499 | 0.400 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.371 |
LIG_FHA_1 | 63 | 69 | PF00498 | 0.219 |
LIG_FHA_2 | 246 | 252 | PF00498 | 0.564 |
LIG_FHA_2 | 57 | 63 | PF00498 | 0.216 |
LIG_GBD_Chelix_1 | 216 | 224 | PF00786 | 0.255 |
LIG_LIR_Gen_1 | 166 | 173 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 3 | 14 | PF02991 | 0.241 |
LIG_LIR_Gen_1 | 59 | 68 | PF02991 | 0.258 |
LIG_LIR_Nem_3 | 166 | 171 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 3 | 9 | PF02991 | 0.265 |
LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.290 |
LIG_MAD2 | 109 | 117 | PF02301 | 0.202 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.297 |
LIG_SH3_3 | 249 | 255 | PF00018 | 0.681 |
LIG_SH3_3 | 301 | 307 | PF00018 | 0.631 |
LIG_TRAF2_1 | 278 | 281 | PF00917 | 0.262 |
LIG_TRAF2_1 | 290 | 293 | PF00917 | 0.352 |
LIG_TRAF2_1 | 330 | 333 | PF00917 | 0.551 |
MOD_CDC14_SPxK_1 | 116 | 119 | PF00782 | 0.256 |
MOD_CDK_SPxK_1 | 113 | 119 | PF00069 | 0.205 |
MOD_CK1_1 | 245 | 251 | PF00069 | 0.617 |
MOD_CK1_1 | 298 | 304 | PF00069 | 0.677 |
MOD_CK1_1 | 74 | 80 | PF00069 | 0.301 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.202 |
MOD_CK2_1 | 101 | 107 | PF00069 | 0.293 |
MOD_CK2_1 | 275 | 281 | PF00069 | 0.237 |
MOD_CK2_1 | 287 | 293 | PF00069 | 0.237 |
MOD_CK2_1 | 305 | 311 | PF00069 | 0.635 |
MOD_CK2_1 | 56 | 62 | PF00069 | 0.216 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.566 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.596 |
MOD_GlcNHglycan | 244 | 247 | PF01048 | 0.621 |
MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.638 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.454 |
MOD_GSK3_1 | 242 | 249 | PF00069 | 0.636 |
MOD_GSK3_1 | 292 | 299 | PF00069 | 0.587 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.216 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.216 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.239 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.241 |
MOD_N-GLC_1 | 175 | 180 | PF02516 | 0.379 |
MOD_N-GLC_1 | 85 | 90 | PF02516 | 0.455 |
MOD_N-GLC_2 | 56 | 58 | PF02516 | 0.402 |
MOD_NEK2_1 | 323 | 328 | PF00069 | 0.425 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.249 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.206 |
MOD_PIKK_1 | 292 | 298 | PF00454 | 0.443 |
MOD_PKA_2 | 118 | 124 | PF00069 | 0.407 |
MOD_PKA_2 | 220 | 226 | PF00069 | 0.255 |
MOD_Plk_1 | 163 | 169 | PF00069 | 0.425 |
MOD_Plk_1 | 44 | 50 | PF00069 | 0.202 |
MOD_Plk_2-3 | 275 | 281 | PF00069 | 0.225 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.243 |
MOD_ProDKin_1 | 113 | 119 | PF00069 | 0.260 |
MOD_ProDKin_1 | 300 | 306 | PF00069 | 0.721 |
MOD_SUMO_rev_2 | 329 | 339 | PF00179 | 0.545 |
TRG_DiLeu_BaEn_2 | 163 | 169 | PF01217 | 0.477 |
TRG_ENDOCYTIC_2 | 274 | 277 | PF00928 | 0.648 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.249 |
TRG_ER_diArg_1 | 283 | 285 | PF00400 | 0.315 |
TRG_NLS_MonoExtC_3 | 129 | 134 | PF00514 | 0.335 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3L9 | Leptomonas seymouri | 72% | 100% |
A0A1X0NPW3 | Trypanosomatidae | 54% | 100% |
A0A3R7NGB6 | Trypanosoma rangeli | 57% | 98% |
A0A3S7WQ17 | Leishmania donovani | 86% | 98% |
A4HTD8 | Leishmania infantum | 86% | 98% |
C9ZUH4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9ALD1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 98% |
O17453 | Schistosoma mansoni | 37% | 81% |
O35226 | Mus musculus | 36% | 90% |
O61742 | Caenorhabditis elegans | 39% | 98% |
O82143 | Oryza sativa subsp. japonica | 37% | 84% |
O94444 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 37% | 100% |
P38886 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 39% | 100% |
P55034 | Arabidopsis thaliana | 39% | 88% |
P55035 | Drosophila melanogaster | 34% | 86% |
P55036 | Homo sapiens | 35% | 90% |
Q4QIH4 | Leishmania major | 86% | 100% |
Q58DA0 | Bos taurus | 35% | 89% |
V5DQ49 | Trypanosoma cruzi | 55% | 99% |